Thoracic stereotactic body radiation therapy plus first-line tyrosine kinase inhibitors for patients with epidermal growth factor receptor-mutant polymetastatic non-small-cell lung cancer: A propensity-matched retrospective study

The role of thoracic stereotactic body radiation therapy (SBRT) in addition to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in EGFR-mutant polymetastatic non-small-cell lung cancer (NSCLC) has not been well established. This retrospective study aimed to evaluate the effi...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xia, Lu, Zhiqin, Zeng, Zhimin, Cai, Jing, Xu, Peng, Liu, Anwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8448028/
https://www.ncbi.nlm.nih.gov/pubmed/34664886
http://dx.doi.org/10.1097/MD.0000000000027279

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8448028/
https://www.ncbi.nlm.nih.gov/pubmed/34664886
http://dx.doi.org/10.1097/MD.0000000000027279

Ejemplares similares